Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ClC-2 is a voltage-gated chloride ion channel encoded by the CLCN2 gene. It is a member of the CLC family characterized by a homodimeric structure with each subunit forming an independent pore for selective passage of chloride ions across cell membranes. The protein contains transmembrane domains with conserved α-helices and two cytoplasmic CBS domains involved in regulation. ClC-2 is widely expressed throughout mammalian tissues—including brain (neurons and glia), heart, skeletal muscle, kidney, pancreas, liver, lung, gastrointestinal tract—and plays key roles in maintaining electrical excitability and ionic balance within cells. In neurons it helps regulate intracellular chloride concentration critical for inhibitory neurotransmission via GABA receptors; in glial cells it contributes to K+ uptake following intense neuronal activity. Mutations or dysfunctions in ClC-2 have been linked to neurological diseases such as certain epilepsies and leukodystrophies—especially when associated with accessory proteins like GlialCAM—or retinal degenerative disorders. The development of specific inhibitors like AK-42 has enabled more precise study but also highlights therapeutic challenges due to its broad physiological roles.[1][3][4][5]
AK-42 and similar inhibitors block the selective passage of Cl– ions through the ClC-2 channel, thereby modulating neuronal excitability and ion homeostasis. This can affect processes such as GABAergic inhibition by altering intracellular chloride concentrations.[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ClC-2 chloride channel (ClC-2).